Use access key #2 to skip to page content.
$24.40 0.84 (3.57%)
11/21/2008 4:02 PM

Merck & Co., Inc. (MRK)

CAPS Rating:
****

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating MRK

Add Stock to Watchlist

What the Community Thinks

Total Members

2056 Outperforms
170 Underperforms
 

All-Stars

564 Outperforms
49 Underperforms
 

Wall Street

21 Outperforms
0 Underperforms
 

Members bullish on MRK are also bullish on:

Members bearish on MRK are also bearish on:

Ticker Tags

S&P 500 (469), Major 2005 Lawsuit (7), Large Cap (279), Multinational Company (16), Major 2006 Lawsuit (3), Big Pharma (12), Dow (30), Optionable (26), Pharmaceuticals (148), Dividend (191), SEC investigation (7), New Jersey (8)
Suggest a tag

Merck & Co., Inc. At A Glance

Current Price: $24.40
Last Trade Time: 11/21/2008 4:02 PM
Open: $23.90
Previous Close: $23.56
Daily Range: $22.82 - $24.46
52-Week Range: $23.18 - $61.62
Volume: 24,134,253
Market Cap: $49.81B
P/E Ratio: 11.17
Compare Our Special Broker Offers!

Stock Trends

MRK VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for MRK

More Headlines...

Top Bull Pitch

Recs

12

Merck & Co., Inc. (MRK)

Avatar biotechmgr (99.87) Submitted: 3/15/08 3:19 PM

Merck is well positioned to become the industry leader over the next 5 years. The product pipeline has swelled under the leadership of Dr. Peter Kim. Innovations in vaccines are focusing on prevention not just cures. Cost savings efforts as well as focus on speed are continuous. Merck wants to be th...More

Replies: 4 | Reply | Permalink

Top Bear Pitch

Recs

2

Merck & Co., Inc. (MRK)

Avatar 3kidsjones (29.25) Submitted: 10/07/06 8:43 AM

Has had a nice run-up recently, but too many problems ahead for this major pharma to sustain the trend...look out below

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 334 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (MRK)

Avatar nukousa (98.59) Submitted: 11/20/08 8:52 PM : Outperform Start Price: $23.90 MRK Score: 3.76

What did everyone find magical cures? I think not. We are growing old fast and will need meds to prolong life.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MRK)

Avatar jimstuy (78.85) Submitted: 11/20/08 4:50 PM : Outperform Start Price: $23.90 MRK Score: 3.76

low P/E number in these troubled times makes MRk an attractive long.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MRK)

Avatar dpid (< 20) Submitted: 11/19/08 4:46 PM : Outperform Start Price: $25.18 MRK Score: 2.26

drugs + dividends

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MRK)

Avatar greenbodhi (88.02) Submitted: 11/18/08 10:34 PM : Outperform Start Price: $26.00 MRK Score: 5.57

Merck's Gardasil has shown to be effective for both females and males in preventing HPV, the most common sexual tranmitted infection. Public health officials are warm to prevention methods, and now that it will be made available to boys, moms will be less resistant to its use.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MRK)

Avatar ETFinnovators (88.44) Submitted: 11/18/08 9:44 PM : Outperform Start Price: $26.00 MRK Score: 5.57

Dissecting Defensive Dividend Stocks & ETFs


The accompanying table includes 47 U.S.-listed companies with market caps over $10B and dividend yields over 5%, excluding all companies from the following sectors or industry groups: finance, insurance, consumer cyclical products, retailers, and basic materials in favor of healthcare, consumer staples such as tobacco, telecom services, energy, and utilities. Also, the following dividend ETFs are included in the table as a comparison:

1.) iShares Dow Jones Select Dividend (DVY)
2.) WisdomTree Dividend Top 100 (DTN)
3.) SPDR S&P Dividend ETF (SDY)
4.) PowerShares High Yield Dividend Achievers (PEY)
5.) Vanguard Dividend Appreciation (VIG)
6.) PowerShares International Dividend Achievers (PID)
7.) PowerShares Dividend Achievers (PFM)

Some of favorite stocks on the list which I have wrote about previously include Altria Group (MO) and Pfizer (PFE) with dividend yields near 8% each. Also, AT&T (T) and Verizon (VZ) are attractive from the telecom services space with yields of about 6% each, with many foreign telcos yielding even more such as Swisscom (SCMWY), Telstra (TLSYY), France Telecom (FTE), Deutsche Telekom (DT).

Several values also appear in the beaten up energy sector, such as Sasol (SSL), British Petroleum (BP), PetroChina (PTR), and Repsol YPF (REP). Gas pipeline operator Kinder Morgan Energy Partners (KMP) was the best performing stock and only company to post a gain over the past year, followed by two utilities – Progress Energy (PGN) and Duke Energy (DUK).

For more things defensive, check out the ETF Innovators [ETFI] Highly Defensive PerformIdex of 40 companies based in the U.S., Canada, and Europe with market caps over $10B, which are the leaders by market cap in their defensive industry groups and have outpaced the overall market and existing defensive ETFs over the past year.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 334 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 21 of 21  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackUBS 85.75 10/17/08 Outperform NS $27.54-11.40%-17.56%+6.16
TrackJPMorgan < 20 06/25/08 Outperform NS $36.35-32.88%-42.43%+9.55
TrackJimCramer 85.65 11/26/07 Outperform 3W $55.56-56.08%-46.20%-9.88
TrackGaryBSmith 79.82 10/26/07 Outperform 3W $55.55-56.08%-50.64%-5.44
TrackBernstein 89.78 10/24/07 Outperform NS $54.37-55.12%-49.85%-5.28
TrackJohnKeeley < 20 09/30/07 Outperform NS $49.87-51.07%-50.30%-0.77 Toggle the visibility of 60-Second Pitch and replies
TrackEveillard 85.91 09/30/07 Outperform NS $49.87-51.07%-50.30%-0.77 Toggle the visibility of 60-Second Pitch and replies
TrackDodgeCox 94.99 09/30/07 Outperform NS $49.87-51.07%-50.30%-0.77 Toggle the visibility of 60-Second Pitch and replies
TrackSnow 67.69 09/30/07 Outperform NS $49.87-51.07%-50.30%-0.77 Toggle the visibility of 60-Second Pitch and replies
TrackEdwardOwens 99.48 09/30/07 Outperform NS $49.87-51.07%-50.30%-0.77 Toggle the visibility of 60-Second Pitch and replies
TrackHillman 72.20 09/30/07 Outperform NS $49.87-51.07%-50.30%-0.77 Toggle the visibility of 60-Second Pitch and replies
TrackBRogers 96.96 09/30/07 Outperform NS $49.87-51.07%-50.30%-0.77 Toggle the visibility of 60-Second Pitch and replies
TrackBofASec 95.85 09/13/07 Outperform NS $48.72-49.92%-48.95%-0.97
TrackCowenandCo 78.45 08/06/07 Outperform NS $49.02-50.22%-47.41%-2.81
TrackAGEdwards 87.66 07/12/07 Outperform NS $47.71-48.85%-50.40%+1.55
TrackBMOCapital 86.58 04/13/07 Outperform NS $47.54-48.68%-47.52%-1.16
TrackScottBleier 75.69 04/13/07 Outperform 3M $47.72-48.86%-47.82%-1.05
TrackCitigroup < 20 02/26/07 Outperform NS $41.78-41.60%-48.00%+6.40
TrackBearStearns 25.14 01/03/07 Outperform NS $41.49-41.18%-46.69%+5.50
TrackDeutscheSec < 20 10/24/06 Outperform NS $43.06-43.33%-44.76%+1.43
TrackLehmanBros < 20 08/21/06 Outperform NS $37.69-35.26%-41.69%+6.43

Results 1 - 21 of 21  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.